Sub Heading

Clinical Trials Details

Cemiplimab vs Cemiplimab plus Fianlimab in Patients with Colorectal Cancer with Minimal Residual Disease Following Definitive Surgery and Chemotherapy

IRB Protocol Number
NSABP F13

Clinical Trial Categories

  • Colorectal Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Stage II/III or oligometastatic stage IV

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.